Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2023-04-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
2022年年度审计报告
Regulatory Filings
2023-04-28 Chinese
关于公司2023年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding its expected related party transactions for the year 2023. It includes details about the nature, estimated amounts, and approval process of these transactions. The document is relatively short (3934 characters) and focuses on disclosure of anticipated related party dealings rather than presenting comprehensive financial statements or audit results. It does not contain full financial data or detailed financial analysis typical of annual or interim reports. It also does not fit categories like management changes, earnings releases, or legal proceedings. The content aligns with a regulatory announcement about related party transactions, which is a common type of regulatory filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-04-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the third meeting of the third board of directors of the company, dated April 28, 2023. It includes approvals of various reports such as the 2022 annual general manager work report, board work report, financial statements, profit distribution plan, internal control self-evaluation report, and the 2023 first quarter report. It also mentions submission of these reports to the 2022 annual shareholders meeting for approval. The document contains substantive financial data (e.g., revenue, net profit, assets) and detailed management decisions. It is not merely an announcement of a report publication but contains actual financial and operational information. The document is a board meeting resolution announcement covering multiple management and financial reports, including the annual report and quarterly report. Given the nature of the content focusing on board meeting decisions and management reports, the best fitting category is Board/Management Information (MANG).
2023-04-28 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company, detailing the approval of various reports and proposals including the 2022 Supervisory Board Work Report, 2022 Financial Statements, 2022 Profit Distribution Proposal, 2022 Annual Report, Internal Control Self-Evaluation Report, and the 2023 First Quarter Report. It also mentions that these reports and proposals will be submitted to the 2022 Annual General Meeting for approval. The document itself does not contain the full financial reports but rather the resolutions approving them and references to where the full reports can be found (e.g., on the cninfo website). The document length is 4262 characters, which is relatively short and consistent with an announcement rather than a full report. According to the "Menu vs Meal" rule, this is an announcement of the Supervisory Board meeting resolutions and approvals, not the full reports themselves. Therefore, the document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of supervisory board resolutions and approvals related to various reports and proposals, but does not contain the full reports or detailed financial data itself.
2023-04-28 Chinese
2022年度独立董事述职报告（肖伟）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2022 from Dabao Medical Technology Co., Ltd. It details the independent director's attendance at board meetings, opinions on management appointments, supervision activities, protection of investor rights, and committee work during the year. The content is a narrative report on the director's duties and observations rather than a financial report or announcement. It does not contain financial statements, earnings data, or regulatory filings. It is not a proxy statement, voting result, or remuneration report. The document is a management-related report focusing on governance and director activities, fitting best under Board/Management Information (MANG). The document length is 2322 characters, which is relatively short but contains substantive content about board and management activities, not just an announcement or certification. Therefore, the classification is MANG with high confidence.
2023-04-28 Chinese
2022年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2022 Annual Report Summary" of 大博医疗科技股份有限公司, which indicates it is a summary of the full annual report. It contains detailed information about the company's business, products, financial data for the year 2022, including revenue, net profit, assets, and shareholder information. The document includes comprehensive financial and operational data typical of an annual report. It is not a brief announcement or a presentation, nor is it a transcript or a regulatory filing. The length (over 11,000 characters) and the detailed financial and business information confirm it is the actual annual report summary, which is a part of the official yearly report covering company activity and full financial performance. Therefore, the appropriate classification is Annual Report (10-K). FY 2022
2023-04-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.